Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of Lucentis Injections for DME in Cataract Surgery Patients
NCT04063358Phase 3Unknown
- Sponsor
- Naval Medical University
- Start
- Aug 2019
- Primary completion
- Aug 2021
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of ranibizumab in diabetic macular edema (DME), sponsored by Naval Medical University. Status: unknown.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT04063358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04063358.